Brain Cancer Trial, Recruiting NCT07563777 Sponsor: Longevity Metrics, Inc. Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07563777
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who are willing and able to sign a consent form, or who have a legally authorised representative (such as a family member or carer) who can provide consent on their behalf
  • People who are willing to take part in follow-up appointments or check-ins over a period of time

Who may not be able to join:

  • People under the age of 18 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: William E Brandenburg, MD, Longevity Metrics, Inc.

Phone: 3035010016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Longevity Metrics, Inc.
Registry
ClinicalTrials.gov
Start date
9 February 2025
Est. completion
31 December 2099

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

All-Cause Mortality; Cause-Specific Mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov